Veriheal

MARCH 20, 2023

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Smith cited results from clinical trials showing that MDMA holds promise in the treatment of PTSD. Minnesota Rep. Missouri Rep.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

Cannabis Law Report

FEBRUARY 26, 2022

The organization has, they say, ……evaluated patient access, affordability, equity, and product safety. With a decline in legislative improvements in state medical cannabis programs, millions of patients are left with limited or no access,” ASA Executive Director Debbie Churgai said. “It Pennsylvania State Rep.

Access 98

Access Law Patients Programs 98

Cannabis Law Report

JULY 13, 2022

Here’s what they posted 12 July 2022. Import, Advertising and Supply Compliance Priorities 2022-23. 12 July 2022. Import, Advertising and Supply Compliance Priorities 2022-23. Compliance Priority. Deter and address the unlawful import, advertising and supply of unapproved therapeutic goods associated with COVID-19.

Compliance 52

Compliance Compliance Wellness and Beauty Vaping 52

Illinois News Joint

FEBRUARY 8, 2023

With a philosophy rooted in trauma-informed care, they believe in client-led healing and strive to truly listen and collaborate with patients to create individualized treatment plans that meet unique needs and lifestyles. We work with patients of all ages with a wide variety of conditions.

Patients 91

Patients Treatment Environment Conditions 91

Cannabis Law Report

SEPTEMBER 29, 2022

Australia’s drugs regulator issues 73 infringement notices over claims prescriptions could treat conditions such as cancer and epilepsy. 27 September 2022. It is also alleged that the unlawful advertising included unapproved references to the treatment of serious diseases or conditions, including in some cases cancer and epilepsy.

Epilepsy 52

Epilepsy Conditions Media Medicine 52

TheAnswerPage

MAY 16, 2022

A seizure disorder is a qualifying condition in many medical marijuana state programs. The effect of epidiolex (cannabidiol) on serum levels of concomitant anti-epileptic drugs in children and young adults with treatment-resistant epilepsy in an expanded access program. Friedman D, Cilio MR, Tilton N, et al. See the Answer.

Epilepsy 52

Epilepsy Programs Treatment CBD 52

MMJ Recs

JANUARY 20, 2024

Let’s take a closer look at medical marijuana laws in Maryland and how they affect those in need of MMJ treatment! The state’s thoughtful approach seeks to ensure that those with genuine medical needs have access to this alternative treatment while maintaining a balance between patient care and preventing misuse.

Law 52

Law Marijuana Patients Chronic Pain 52

Cannabis Law Report

SEPTEMBER 1, 2022

UK medical cannabis charity, Sapphire Medical Foundation, has secured new funding to support access to prescriptions during the cost-of-living crisis. . From Wednesday 31 August, UK and Channel Island residents can apply for a grant to fully support their medical cannabis prescription, in the second grant round of 2022.

Treatment 52

Treatment Chronic Pain Access Patients 52

The Cannigma

JUNE 25, 2022

Poland established a medical cannabis program in 2017, which allows for a range of cannabis products to be prescribed for a range of medical conditions. Qualifying conditions include chronic pain, multiple sclerosis, spasticity, chemo-induced nausea, and treatment-resistant epilepsy. Poland and cannabis.

Legalization 108

Legalization Supply Chain Chronic Pain Tincture 108

The Cannigma

JULY 12, 2022

Roll out of the program has been slow, and as of June 2022, there were still no doctors certified to issue prescriptions, no licensed dispensaries, and no legal farming of cannabis products. Unlike other states, Alabama requires doctors to document a failure of conventional medical treatment before issuing a medical cannabis prescription.

Legalization 122

Legalization Chronic Pain Programs Treatment 122

Cannabis Law Report

JANUARY 20, 2022

19 January 2022. Emergency access to restricted drugs has been restored by recent regulatory amendments to Health Canada’s Special Access Program (SAP). SAP allows health care professionals to request access to non-marketed drugs and medical devices not yet authorized for sale in Canada, on behalf of a patient.

Access 52

Access Programs Treatment Therapy 52

The Cannigma

JULY 5, 2022

The program was legalized in 2015 and patients with qualifying conditions can get a prescription for up to 20oz of low THC oil, capsules, patches, or lotion. But it is a medical program in name only, because as of June 2022 there were no licensed dispensaries in Georgia. In 2015, Georgia legalized possession of up 20 fl.

Law 96

Law Decriminalization Programs Patients 96

Cannabis Law Report

DECEMBER 21, 2021

This UK-based company caught our attention in 2021 for its team of renowned psychedelic researchers, including chief research officer Professor David Nutt, chief medical officer Dr. Ben Sessa, and head of ketamine psychotherapy Dr. Celia Morgan, as well as its unique studies into ketamine treatment for addiction and gambling addiction.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

Cannabis Law Report

APRIL 21, 2022

Apr 20, 2022. NEW ORLEANS , April 20, 2022 /PRNewswire/ — Gary Hess , the founder and CEO of the Veterans Alliance for Holistic Alternatives (VAHA), announced today that four groundbreaking physicians are joining the VAHA Medical Advisory Board. “The patient is our textbook. “The patient is our textbook.

Therapy 52

Therapy Education Treatment Patients 52

Cannabis Law Report

SEPTEMBER 7, 2022

Since the legalisation of medical cannabis in the UK in 2018, there is little education surrounding medical cannabis and how it can help a large variety of conditions, should traditional medicine leave patients with an ‘unmet clinical need.’ . Cantourage Clinic is a leading medical cannabis clinic in the UK with a difference. .

Patients 52

Patients Conditions Treatment Education 52

Veriheal

FEBRUARY 9, 2023

Although many rely on imaging scans to diagnose illnesses and get treatment of various kinds, getting into the enclosed chamber can be stressful. All imaging and behavioral data will be accessible to the public after the study is complete. Do not attempt to self-diagnose or prescribe treatment based on the information provided.

Clinical Trials 98

Clinical Trials Research and Development Data Collective 98

Cannabis Law Report

JULY 21, 2022

London, UK July 19, 2022. COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that it has appointed Kabir Nath as Chief Executive Officer, effective August 1, 2022.

Therapy 52

Therapy Research and Development Pharmaceutical Patients 52

MMJ Recs

FEBRUARY 9, 2022

So that more people can gain access to the treatment, the Louisiana MMJ program continues to expand, with more qualifying conditions added to the list as well as more cannabis included under the MMJ umbrella. The first is qualifying for MMJ based on the qualified conditions list.

Marijuana 52

Marijuana Conditions Access Chronic Pain 52

Cannabis Law Report

FEBRUARY 19, 2022

The AMCC anticipates that applicants may submit licenses to grow and/or manufacture medical cannabis on September 1, 2022. Under current law , the Florida Department of Health (FDOH) is responsible for overseeing the medical cannabis program, including issuing licenses to medical cannabis treatment centers.

Legalization 97

Legalization Seed-To-Sale Programs Dispensary 97

Cannabis Law Report

APRIL 14, 2022

Local governments may also impose zoning conditions on cannabis facilities, including but not limited to buffer zones, density conditions, hours of operation, odor control requirements, necessary operating permits, and storefront characteristics.

Environment 52

Environment Agriculture Compliance Compliance 52

MMJ Recs

JUNE 11, 2024

Permanent Marker Permanent Marker is a modern cannabis strain released in 2022. Permanent Marker offers a compelling option for addressing various medical conditions, thanks to its elevated THC content. Medical patients appreciate ACDC for its ability to alleviate chronic pain conditions.

Strains 52

Strains Chronic Pain Hybrid Indica 52

Cannabis Law Report

JANUARY 3, 2022

The Czech Republic legalized therapeutic cannabis for selected patients in 2015, and health insurance companies have been covering up to 90% of the cost of the treatment since 2020. According to official data cited by the Czech News Agency (CTK), the treatment helped improve the health condition and well-being of patients in 69% of cases.

Media 52

Media Chronic Pain Patients Treatment 52

PrestoDoctor

FEBRUARY 13, 2023

Learn about how to become a medical marijuana patient so you can get access to medical cannabis in Missouri. As of December 8th, 2022, patient/caregiver cultivation ID fees are reduced to $50. This signature means that, in their professional opinion, medical marijuana will benefit your condition.

Marijuana 52

Marijuana Conditions Patients Cultivation 52

MMJ Recs

NOVEMBER 14, 2022

Medical marijuana helps to improve the lives of Maryland residents who suffer from a wide range of medical conditions. Maryland voters will get to vote on whether recreational marijuana should become legal in the state in November 2022. What Are The Qualifying Conditions For Medical Marijuana In Maryland? Wasting syndrome.

Dispensary 105

Dispensary Patients Programs Recreational 105

Cannabis Law Report

AUGUST 24, 2022

25 August 2022. New research from the University of Sydney’s Lambert Initiative finds most Australians are still medicating with illicit cannabis, although numbers accessing prescription products have risen dramatically. People using illicit products were more likely to be treating mental health or sleep conditions.

Medicine 52

Medicine Legalization Chronic Pain Access 52

The Cannigma

DECEMBER 20, 2022

Since 2011, treatment may be offered to drug-dependent offenders as an alternative to prison only if the offender is sentenced to imprisonment for six months to two years and agrees to undergo the treatment course. There is no national cannabis program; patients can only access cannabinoid-based medications, not the plant itself.

Law 52

Law Decriminalization Cannabinoids Treatment 52

Cannabis Law Report

MAY 12, 2022

May 11, 2022 02:00 AM Eastern Daylight Time. It brings access to NCEs that we can take into Phase 1 studies in the near term, coupled with access to a drug discovery pipeline that we can shape together as our experience ever deepens in the psychedelic drug development space.

Medicine 52

Medicine Research and Development Clinical Trials Treatment 52

Cannabis Law Report

JUNE 9, 2022

We understand the number of people who will need medical treatment due to this exposure. The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin.

Seed-To-Sale 52

Seed-To-Sale Legalization Cultivation Medicine 52

Cannabis Law Report

APRIL 21, 2022

Commercialization & Patient Access · Any City, Any State, California. MAPS PBC is pioneering new forms of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for post-traumatic stress disorder (PTSD). About MAPS Public Benefit Corporation (MAPS PBC). Executive Summary.

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

Cannabis Law Report

APRIL 21, 2022

and Canada highlights mounting cases of cannabis poisoning among pets and sheds new light on symptoms, treatments, and outcomes. Richard Quansah Amissah of the Ontario Veterinary College at the University of Guelph in Ontario, Canada, and colleagues present these findings in the open-access journal PLOS ONE on April 20, 2022.

Pets 52

Pets Research and Development Topical Consumption 52

MMJ Recs

NOVEMBER 15, 2021

Sooner State MMJ patients have access to a medical marijuana program that is the envy of patients in other states. With almost 10% of the population availing of MMJ treatment, Oklahoma has more MMJ patients per capita than any other state. In February 2021, the Oklahoma House passed House Bill 2022.

Dispensary 85

Dispensary Patients Treatment Vaping 85

MMJ Recs

SEPTEMBER 15, 2021

However, the legalization of medical marijuana in Missouri is already proving to be hugely beneficial to people who suffer from a wide variety of medical conditions. A group called Fair Access Missouri has filed a series of potential petitions to legalize recreational MMJ in the state. It is hoped that a vote will happen in 2022.

Recreational 52

Recreational Dispensary Conditions Access 52

Cannabis Law Report

JUNE 8, 2022

Published: Jun 07, 2022. Experienced healthcare leaders bring decades of experience in global drug commercialization and patient access. MDMA-assisted therapy, a novel treatment for PTSD with FDA breakthrough therapy designation, is on track for NDA submission in 2023 pending results of the confirmatory Phase 3 trial.

Therapy 52

Therapy Treatment Access Patients 52

Cannabis Law Report

MAY 10, 2022

11 May 2022. Of the 248,000 scripts approved for Australians since inception of national medicinal cannabis scheme in 2016, many related to conditions for which the drug has limited evidence of efficacy, a new University of Sydney study shows. First comprehensive study reveals why Australians take medicinal cannabis.

Medicine 52

Medicine Clinical Trials Sleep Data 52

MMJ Recs

MAY 15, 2022

But in the years since 2017, lawmakers have steadily improved Virginia’s medical marijuana program and made it accessible to a wider range of people. From July 1, 2022, MMJ patients will not need to get a Board Registration card from the Virginia Board of Pharmacy in order to go to a dispensary and buy MMJ products.

Patients 52

Patients Marijuana Pharmaceutical Dispensary 52

The Cannigma

NOVEMBER 20, 2022

In 2016, a new law was introduced that allowed people with drug charges outside of trafficking to apply for alternative treatment rather than prison. Patients with qualifying conditions can get a prescription from a specialized doctor and fill the prescription at pharmacies. Qualifying conditions include. CBD regulations.

Law 52

Law Programs Cultivation Recreational 52

Cannabis Law Report

MAY 31, 2022

Food and Drug Administration (FDA) approved esketamine (a component of Ketamine and sold under the brand name Spravato) for treatment-resistant depression. 2022 Active FDA Clinical Trials and State-Regulated Systems. Journey Colab has a Phase I trial planned in 2022 for a synthetic version of mescaline. Federal Legal Status.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52